78 related articles for article (PubMed ID: 30865704)
1. Homoarginine and inhibition of human arginase activity: kinetic characterization and biological relevance.
Tommasi S; Elliot DJ; Da Boit M; Gray SR; Lewis BC; Mangoni AA
Sci Rep; 2018 Feb; 8(1):3697. PubMed ID: 29487337
[TBL] [Abstract][Full Text] [Related]
2. Screening of commonly prescribed drugs for effects on the CAT1-mediated transport of L-arginine and arginine derivatives.
Banjarnahor S; König J; Maas R
Amino Acids; 2022 Jul; 54(7):1101-1108. PubMed ID: 35377022
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of SLCO4C1 as a biological marker in hepatocellular carcinoma based on anoikis classification features.
Wang T; Guo K; Yang S; Zhang D; Cui H; Yin J; Yuan S; Wang Y; Qi Y; Wu W
Aging (Albany NY); 2024 Jan; 16(2):1440-1462. PubMed ID: 38226966
[TBL] [Abstract][Full Text] [Related]
4. Remote effects of kidney drug transporter OAT1 on gut microbiome composition and urate homeostasis.
Ermakov VS; Granados JC; Nigam SK
JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37937647
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Supplementation of Sodium Nitrate vs. Sodium Chloride Increases Homoarginine Synthesis in Young Men Independent of Exercise.
Tsikas D; Maassen N; Thorns A; Finkel A; Lützow M; Röhrig MA; Blau LS; Dimina L; Mariotti F; Beckmann B; Shushakov V; Jantz M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142560
[TBL] [Abstract][Full Text] [Related]
6. Bile Acid-Drug Interaction via Organic Anion-Transporting Polypeptide 4C1 Is a Potential Mechanism of Altered Pharmacokinetics of Renally Excreted Drugs.
Yamauchi M; Sato T; Otake A; Kumondai M; Sato Y; Kikuchi M; Maekawa M; Yamaguchi H; Abe T; Mano N
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955643
[TBL] [Abstract][Full Text] [Related]
7. Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction.
Kleist CJ; Choe CU; Atzler D; Schönhoff M; Böger R; Schwedhelm E; Wicha SG
Amino Acids; 2022 Jun; 54(6):889-896. PubMed ID: 35618975
[TBL] [Abstract][Full Text] [Related]
8. L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact.
Surrer DB; Fromm MF; Maas R; König J
Metabolites; 2022 Mar; 12(4):. PubMed ID: 35448460
[TBL] [Abstract][Full Text] [Related]
9. The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
Cunha RSD; Azevedo CAB; Falconi CA; Ruiz FF; Liabeuf S; Carneiro-Ramos MS; Stinghen AEM
Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324674
[TBL] [Abstract][Full Text] [Related]
10. Transport of L-Arginine Related Cardiovascular Risk Markers.
Banjarnahor S; Rodionov RN; König J; Maas R
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33302555
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway.
Hu X; Han T; Bian Y; Tong H; Wen X; Li Y; Wan X
Oncol Rep; 2020 Mar; 43(3):919-929. PubMed ID: 32020231
[TBL] [Abstract][Full Text] [Related]
12. The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine.
Taghikhani E; Maas R; Fromm MF; König J
PLoS One; 2019; 14(3):e0213747. PubMed ID: 30865704
[TBL] [Abstract][Full Text] [Related]
13. Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and L-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells.
Taghikhani E; Maas R; Taudte RV; Gessner A; Fromm MF; König J
Amino Acids; 2020 Jul; 52(6-7):975-985. PubMed ID: 32642843
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
15. The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B.
Chafai A; Fromm MF; König J; Maas R
Sci Rep; 2017 Jul; 7(1):4767. PubMed ID: 28684763
[TBL] [Abstract][Full Text] [Related]
16. Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA).
Tain YL; Hsu CN
Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28272322
[TBL] [Abstract][Full Text] [Related]
17. Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease.
Papageorgiou N; Androulakis E; Papaioannou S; Antoniades C; Tousoulis D
Amino Acids; 2015 Sep; 47(9):1741-50. PubMed ID: 26123985
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
